Christopher Upton

Array ( [id] => 7092908 [patent_doc_number] => 20010034024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-25 [patent_title] => 'Mutations in and genomic structure of HERG - a long QT syndrome gene' [patent_app_type] => new [patent_app_number] => 09/735995 [patent_app_country] => US [patent_app_date] => 2000-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 36596 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20010034024.pdf [firstpage_image] =>[orig_patent_app_number] => 09735995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6875109 [patent_doc_number] => 20010000228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-04-12 [patent_title] => 'Use of a modified baculovirus containing exogenous nucleic acid for the manufacture of a medicament for delivering said nucleic acid to the hepatocytes' [patent_app_type] => new-utility [patent_app_number] => 09/729856 [patent_app_country] => US [patent_app_date] => 2000-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4391 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0000/20010000228.pdf [firstpage_image] =>[orig_patent_app_number] => 09729856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7615171 [patent_doc_number] => 06897353 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-24 [patent_title] => 'Yeast-Bacteria shuttle vector' [patent_app_type] => utility [patent_app_number] => 09/729043 [patent_app_country] => US [patent_app_date] => 2000-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6959 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/897/06897353.pdf [firstpage_image] =>[orig_patent_app_number] => 09729043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801233 [patent_doc_number] => 20030096398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Novel nucleic acid molecule' [patent_app_type] => new [patent_app_number] => 09/728552 [patent_app_country] => US [patent_app_date] => 2000-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 223 [patent_figures_cnt] => 223 [patent_no_of_words] => 18758 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096398.pdf [firstpage_image] =>[orig_patent_app_number] => 09728552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 682182 [patent_doc_number] => 07081242 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-25 [patent_title] => 'Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof' [patent_app_type] => utility [patent_app_number] => 09/724822 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 27 [patent_no_of_words] => 21040 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/081/07081242.pdf [firstpage_image] =>[orig_patent_app_number] => 09724822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1094162 [patent_doc_number] => 06821264 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-23 [patent_title] => 'Gene delivery device and gene delivery method' [patent_app_type] => B1 [patent_app_number] => 09/723121 [patent_app_country] => US [patent_app_date] => 2000-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 33 [patent_no_of_words] => 18012 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821264.pdf [firstpage_image] =>[orig_patent_app_number] => 09723121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7631458 [patent_doc_number] => 06635474 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Mammary gland tissue-specific expression system using -casein promoter site of Korean native goat' [patent_app_type] => B1 [patent_app_number] => 09/582490 [patent_app_country] => US [patent_app_date] => 2000-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9467 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635474.pdf [firstpage_image] =>[orig_patent_app_number] => 09582490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1402355 [patent_doc_number] => 06531645 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-11 [patent_title] => 'RAS/P21 transgenic mouse' [patent_app_type] => B1 [patent_app_number] => 09/707938 [patent_app_country] => US [patent_app_date] => 2000-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 22 [patent_no_of_words] => 6585 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531645.pdf [firstpage_image] =>[orig_patent_app_number] => 09707938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 575023 [patent_doc_number] => 07455962 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-11-25 [patent_title] => 'Method for preparing cell fraction containing hemangioblasts' [patent_app_type] => utility [patent_app_number] => 10/130076 [patent_app_country] => US [patent_app_date] => 2000-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 27 [patent_no_of_words] => 11879 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/455/07455962.pdf [firstpage_image] =>[orig_patent_app_number] => 10130076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1096945 [patent_doc_number] => 06822138 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-23 [patent_title] => 'NIK-knockout mice' [patent_app_type] => B1 [patent_app_number] => 09/706236 [patent_app_country] => US [patent_app_date] => 2000-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 5 [patent_no_of_words] => 18230 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/822/06822138.pdf [firstpage_image] =>[orig_patent_app_number] => 09706236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1290738 [patent_doc_number] => 06632978 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Transgenic animals for studying regulation of genes' [patent_app_type] => B1 [patent_app_number] => 09/693011 [patent_app_country] => US [patent_app_date] => 2000-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 9737 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632978.pdf [firstpage_image] =>[orig_patent_app_number] => 09693011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1189437 [patent_doc_number] => 06734295 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-11 [patent_title] => 'Modified CRE recombinase gene for mammals' [patent_app_type] => B1 [patent_app_number] => 09/662128 [patent_app_country] => US [patent_app_date] => 2000-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 6123 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/734/06734295.pdf [firstpage_image] =>[orig_patent_app_number] => 09662128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 985398 [patent_doc_number] => 06924126 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-02 [patent_title] => 'Cloning, expression and characterization of the SPG4 gene responsible for the most frequent form of autosomal spastic paraplegia' [patent_app_type] => utility [patent_app_number] => 09/830902 [patent_app_country] => US [patent_app_date] => 2000-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 15731 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924126.pdf [firstpage_image] =>[orig_patent_app_number] => 09830902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342537 [patent_doc_number] => 06586411 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'System for monitoring the location of transgenes' [patent_app_type] => B1 [patent_app_number] => 09/640198 [patent_app_country] => US [patent_app_date] => 2000-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 10660 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586411.pdf [firstpage_image] =>[orig_patent_app_number] => 09640198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1377231 [patent_doc_number] => 06563015 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) and mutant APP in brain and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/638649 [patent_app_country] => US [patent_app_date] => 2000-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 15364 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/563/06563015.pdf [firstpage_image] =>[orig_patent_app_number] => 09638649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1380390 [patent_doc_number] => 06548055 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Immunologic enhancement with intermittent interleukin-2 therapy' [patent_app_type] => B1 [patent_app_number] => 09/635286 [patent_app_country] => US [patent_app_date] => 2000-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 45 [patent_no_of_words] => 15508 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548055.pdf [firstpage_image] =>[orig_patent_app_number] => 09635286 [rel_patent_id] =>[rel_patent_doc_number] =>)